Literature DB >> 14310575

CURRENT STATUS OF COXSACKIE AND ECHO VIRUSES IN HUMAN DISEASE.

S KIBRICK.   

Abstract

Entities:  

Keywords:  COXSACKIE VIRUS INFECTIONS; ECHO VIRUSES; REVIEW

Mesh:

Year:  1964        PMID: 14310575

Source DB:  PubMed          Journal:  Prog Med Virol        ISSN: 0079-645X


× No keyword cloud information.
  15 in total

1.  Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult.

Authors:  M Longson; F M Cole; D Davies
Journal:  J Clin Pathol       Date:  1969-11       Impact factor: 3.411

2.  An epidemic of ECHO 6 virus infection.

Authors:  A S Mary; J H Swallow
Journal:  Postgrad Med J       Date:  1970-05       Impact factor: 2.401

3.  An epidemic of aseptic meningitis due to echo-virus type 30: epidemiologic features and clinical and laboratory findings.

Authors:  D E Torphy; C G Ray; R S Thompson; J P Fox
Journal:  Am J Public Health Nations Health       Date:  1970-08

4.  Coxsackievirus B4 infection of spinal sympathetic ganglion.

Authors:  G E Burch; K C Chu; K F Soike
Journal:  Experientia       Date:  1981-02-15

Review 5.  Viral myocarditis. A review.

Authors:  J F Woodruff
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

6.  Mononucleosis-like syndrome associated with a multisystem Coxsackie virus type B3 infection in adolescence.

Authors:  J Begovac; V Puntarić; D Borcić; B Barsić; J Zrinscak; I Beus; V Presecki
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

7.  Four cases of vesicular lesions in adults caused by enterovirus infections.

Authors:  C Dechamps; H H Peigue-Lafeuille; H Laveran; J Beytout; H Roger; D Beytout
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Epidemiologic, clinical, and laboratory features of Coxsackie B1-B5 infections in the United States, 1970-79.

Authors:  M Moore; M H Kaplan; J McPhee; D J Bregman; S W Klein
Journal:  Public Health Rep       Date:  1984 Sep-Oct       Impact factor: 2.792

9.  Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.

Authors:  G A Olsen; E R Kern; L A Glasgow; J C Overall
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Myalgic encephalomyelitis--report of an epidemic.

Authors:  K G Fegan; P O Behan; E J Bell
Journal:  J R Coll Gen Pract       Date:  1983-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.